Revived Drug May Serve as New Parkinson’s Treatment
A cancer drug that washed out of clinical trials more than 15 years ago may be the key to slowing the progression of Parkinson’s disease, according to a Northwestern Medicine study.
Browsing: Disease Discoveries
Personalized Approach to Parkinson’s Treatment
Northwestern Medicine scientists have developed a new strategy to treat Parkinson’s disease by mitigating the effects of harmful genetic mutations, according to a recent study.
An Impactful Partnership Between the American Heart Association and Northwestern
This article was originally published in the Breakthroughs Newsletter. Find more stories like this, as…
Activating New Neurons Could Treat Depression
Boosting the activity of newly-created neurons mimicked the effect of antidepressant medication in mouse models, according to a recent study.
Map of Broken Brain Networks Shows Why People Lose Speech in Language-Based Dementia
Northwestern Medicine scientists have pinpointed the location of dysfunctional brain networks that lead loss of language in primary progressive aphasia, a form of dementia.
ALS Drug Grant to Spur Drug Discovery at Northwestern
Two Northwestern University scientists have received a $3.1 million grant from the National Institute on Aging to collaborate and investigate drug therapies for amyotrophic lateral sclerosis (ALS).
Sesame Allergy is More Common Than Previously Recognized
Sesame allergy affects more than 1 million children and adults in the U.S., more than previously known, according to a new Northwestern Medicine study.
New Target for Slowing Breast Cancer’s Spread to Brain
Northwestern Medicine scientists have identified a protein that helps reprogram HER2-positive breast cancer cells to survive in the brain, according to a recent study.
New Approach Shows Promise in Treating Parkinson’s Symptoms
Northwestern Medicine scientists have rescued movement in a mouse model of Parkinson’s disease by restoring the intrinsic discharge of nerve cells within the subthalamic nucleus.
Procedure Proves Effective in Treating Rare Swallowing Disorder
A procedure called POEM significantly improved treatment outcomes among patients with achalasia — a rare swallowing disorder — compared with a standard therapy, according to a clinical trial published in JAMA.